Cardiff Oncology
CRDF
CRDF
82 hedge funds and large institutions have $479M invested in Cardiff Oncology in 2020 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 20
28% less call options, than puts
Call options by funds: $14.1M | Put options by funds: $19.5M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
82
Holding in Top 10
3
Calls
$14.1M
Puts
$19.5M
Top Buyers
| 1 | +$45.9M | |
| 2 | +$28.9M | |
| 3 | +$20.2M | |
| 4 |
CA
Corriente Advisors
Fort Worth,
Texas
|
+$19.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$12.8M |
Top Sellers
| 1 | -$18M | |
| 2 | -$5.17M | |
| 3 | -$4.71M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$4.34M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.05M |